Table 2 Patient demographic and clinical data.
Number of patients | 145 |
|---|---|
Age (years) | 53.7 ± 11.9 |
Sex (M/F) | 88/57 |
Total fused levels | 206 |
Follow-up length (months)(SD) | 32 ± 17 |
Neurological symptoms | |
Myelopathy | 53/145 (37%) |
Radiculopathy | 92/145 (63%) |
Fused levels | |
1 | 84/145 (58%) |
2 | 61/145 (32%) |
Cage materials | |
TM | 48/145 (67%) |
PEEK | 97/145 (33%) |
Successful fusion | 128/145 (88%) |
RASP | 49/145 (34%) |
CASP | 7/145 (5%) |
Cage subsidence | 58/145 (40%) |
JOA score (SD) | |
Preoperative | 11.5 ± 2.1 |
Postoperative | 13.8 ± 2.0 |
Final follow-up | 14.4 ± 2.0 |